RxDoctor Payments DataLook up a doctor →

David Pedowitz, MD

Foot and Ankle Surgery · Bryn Mawr, PANPI 1962562827

Payments from drug & device makers

$1,686,869in general payments, 2019–2025

Across 746 payments — averaging $2261.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$654K
  • Smith+Nephew$510K
  • Integra Lifesciences Corporation$297K
  • Zimmer Biomet$142K
  • Ossio LTD$50K
  • Mirus, LLC$14K
  • plus $20K from 18 others
$290in research payments, 2019–2025

Across 1 payment — averaging $290.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$290

What the payments were for

  • Royalty or licence$910,79756%
  • Consulting fees$148,0359%
  • Speaking & faculty fees$503,12831%
  • Travel & lodging$45,4503%
  • Food & beverage$12,7831%
  • Education$1,6550%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,686,869 in reported general payments places this provider in the 95th percentile of 575 foot and ankle surgery providers in Pennsylvania.

See all foot and ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$253,880
Medicare patients
435
Services billed
2,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine34$668
Ondansetron Hcl84$402
Cephalexin85$279
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$184
Gabapentin20$182
Clindamycin Hcl19$135
Tramadol Hcl28$58
Oxycodone Hcl38$46
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$43

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →